{"id":45081,"date":"2024-09-10T01:00:00","date_gmt":"2024-09-09T19:30:00","guid":{"rendered":"https:\/\/www.equentis.com\/blog\/?p=45081"},"modified":"2026-01-05T15:52:45","modified_gmt":"2026-01-05T10:22:45","slug":"stocks-to-buy-today-10-september-2024","status":"publish","type":"post","link":"https:\/\/www.equentis.com\/blog\/stocks-to-buy-today-10-september-2024\/","title":{"rendered":"20 Stocks To Add To Your Watchlist Today: 10th September 2024"},"content":{"rendered":"<div id=\"bsf_rt_marker\"><\/div>\n<p>It rained IPOs today, with the Share Samadhan, Kross, and My Mudra Fincorp IPOs. The market welcomed the IPOs with a green trading day, which ended with the <a href=\"https:\/\/www.equentis.com\/blog\/what-is-sensex-the-complete-guide\/\">SENSEX<\/a> closing at 81,559.54 and <a href=\"https:\/\/www.equentis.com\/blog\/understanding-nifty-your-key-to-the-indian-stock-market\/\">NIFTY<\/a> closing the day at 24,936.40. Though ending higher than Friday, the rise in the indices was narrow amidst weak <a href=\"https:\/\/www.equentis.com\/blog\/key-global-events-that-can-influence-the-stock-market-this-week-3\/\">global<\/a> cues and a few stocks performing at a level that landed them on the top performers&#8217; list for Monday.&nbsp;<\/p>\n\n\n\n<p>As the market opens at 9:00 AM today, we present 20 stocks to consider adding to your watchlist. Here are ten stocks with the highest trading volume and ten stocks based on their performance at yesterday&#8217;s market close.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\"><strong>Top 10 performers from NIFTY 500 today <\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Sno<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Symbol<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>CMP<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Performance<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">1<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/alembic-pharma_224849\">APLLTD<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">1204.00<\/td><td class=\"has-text-align-center\" data-align=\"center\">8.89 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">2<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/jubilant-pharmova_130019\">JUBLPHARMA<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">1023.00<\/td><td class=\"has-text-align-center\" data-align=\"center\">7.50 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/general-ins.-corp_210174\">GICRE<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">406.00<\/td><td class=\"has-text-align-center\" data-align=\"center\">5.88 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">4<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/one97-communications_208883\">PAYTM<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">636.55<\/td><td class=\"has-text-align-center\" data-align=\"center\">5.42 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">5<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/aether-industries_304714\">AETHER<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">984.80<\/td><td class=\"has-text-align-center\" data-align=\"center\">5.25 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">6<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/pnb-housing-finance_217757\">PNBHOUSING<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">1076.60<\/td><td class=\"has-text-align-center\" data-align=\"center\">5.20 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">7<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/glenmark-life-scienc_301987\">GLS<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">1208.00<\/td><td class=\"has-text-align-center\" data-align=\"center\">5.00 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">8<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/doms-industries_311742\">DOMS<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">2738.00<\/td><td class=\"has-text-align-center\" data-align=\"center\">4.11 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">9<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/gujarat-fluorochemic_295872\">FLUOROCHEM<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">3964.00<\/td><td class=\"has-text-align-center\" data-align=\"center\">4.07 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">10<\/td><td class=\"has-text-align-center\" data-align=\"center\"><a href=\"https:\/\/www.equentis.com\/stocks-screener\/inox-wind_221809\">INOXWIND<\/a><\/td><td class=\"has-text-align-center\" data-align=\"center\">234.90<\/td><td class=\"has-text-align-center\" data-align=\"center\">3.99 %<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">(source: <a href=\"https:\/\/www.equentis.com\/blog\/national-stock-exchange-of-india-functions-features-and-top-companies\/\">NSE<\/a> on 9th September 2024)<\/figcaption><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-ast-global-color-5-color has-vivid-red-background-color has-text-color has-background has-link-color wp-elements-d8af6bf8611dc999cadca191853dd950\">Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. Past performance is not indicative of future results.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\"><strong>Understanding the Top 5 Performing Stocks Today<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Alembic Pharmaceuticals Ltd.:<\/strong><\/h3>\n\n\n\n<p>Alembic Pharmaceuticals has been developing, manufacturing, and marketing pharmaceutical products since 1907. It&#8217;s one of the top 25 players in India&#8217;s domestic formulations market, with a 1.5% market share and a portfolio of around 200 formulation brands, three of which rank in the top 300. Alembic operates 4 R&amp;D centers and 9 manufacturing facilities, with 191 brands under its name. In FY24, the company launched a new division for livestock products, with more launches planned in Animal Health for FY25. In FY2024, Alembic reported a revenue of \u20b96,229 crore (10.2% growth from FY2023), a PAT of \u20b9616 crore (80.1% growth), and a net worth of \u20b94,831 crore (10.5% increase). Moreover, the company\u2019s net debt-to-equity ratio, as of FY2024, stands at 0.06, and its <a href=\"https:\/\/www.equentis.com\/blog\/what-is-roce\/\">RoCE<\/a> is 15%.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Jubilant Pharmova Limited:<\/strong><\/h3>\n\n\n\n<p>Jubilant Pharmova Ltd. is a global pharmaceuticals company with three key segments: pharmaceuticals, contract research and development services, and proprietary novel drugs. It operates in radiopharma, allergy immunotherapy, CDMO sterile injectables, CRDMO, generics, and Proprietary Novel Drugs. In the U.S., it\u2019s the third-largest radiopharmaceutical manufacturer with the second-largest network of 46 radiopharmacies. In FY2024, Jubilant secured a three-year contract with HealthTrust, a major Group Purchasing Organisation in the U.S. The company\u2019s revenue grew by 7% to \u20b96,702.9 crore, while EBITDA jumped by<a href=\"https:\/\/www.jubilantpharmova.com\/uploads\/downloads\/JPM_AnnualReport_2023-24.pdf\" target=\"_blank\" rel=\"noopener\"> 20%<\/a> to \u20b9993.6 crore, with a 160 bps margin expansion to 14.7%. PAT surged by 63% to \u20b9195.5 crore in FY2024. Plus, the Board has proposed a <a href=\"https:\/\/www.jubilantpharmova.com\/uploads\/downloads\/JPM_AnnualReport_2023-24.pdf\" target=\"_blank\" rel=\"noopener\">500%<\/a> dividend, or \u20b95 per equity share, for FY 2023-24.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>General Insurance Corporation of India Limited:<\/strong><\/h3>\n\n\n\n<p>After Independence, the Government of India (GOI) took over 55 Indian insurance companies and the operations of 52 general insurers. In November 1972, GOI established the General Insurance Corporation of India (GIC) to oversee these entities, which were merged into four companies: National Insurance, New India Assurance, Oriental Insurance, and United India Insurance (a GIC subsidiary). GIC focuses on reinsurance and ranks 16th globally in this field. For FY2023-24, your company recorded a gross premium of <a href=\"https:\/\/www.gicre.in\/images\/Intimation_of_Annual_Report_for_Financial_Year_2022-23.pdf\" target=\"_blank\" rel=\"noopener\">\u20b937,181.76 crore<\/a>. However, the underwriting loss rose to \u20b94,006.56 crore due to many catastrophic events during the year. Profit after <a href=\"https:\/\/www.equentis.com\/blog\/income-tax-concepts-the-ultimate-guide\/\">tax<\/a> reached \u20b96,497.30 crore, while <a href=\"https:\/\/www.equentis.com\/blog\/mukul-agrawal-portfolio-shareholdings-investments-all-you-need-to-know\/\">investments<\/a> grew by 11.7% to \u20b996,299 crore, with a market value up 19.1% to \u20b91,40,048 crore in FY2024. Investment income saw a 9.7% rise to \u20b911,625.93 crore. The company\u2019s net worth is \u20b981,330 crore, total assets stand at <a href=\"https:\/\/www.gicre.in\/images\/Intimation_of_Annual_Report_for_Financial_Year_2022-23.pdf\" target=\"_blank\" rel=\"noopener\">\u20b91,78,286 crore<\/a>, and its solvency ratio improved to 3.25 as of FY2024.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>One 97 Communications Ltd. (Paytm).:<\/strong><\/h3>\n\n\n\n<p>One 97 Communications Ltd. (<a href=\"https:\/\/www.equentis.com\/blog\/paytm-shares-up-8-percent-gaining-74-percent-in-3-months\/\">Paytm<\/a>) is India\u2019s leading digital ecosystem for consumers and merchants. Founded in 2000, it had over 333 million customers and 21 million registered merchants by March 31, 2021. In FY2024, Paytm\u2019s merchant subscriptions reached 1.07 crores, and it had 9.6 crore monthly users. The loan distribution business grew significantly, with <a href=\"https:\/\/paytm.com\/document\/ir\/agm\/fy\/-24\/Paytm_Annual_Report_2024.pdf\" target=\"_blank\" rel=\"noopener\">Rs.52,390 crore<\/a> in loans disbursed, marking a 48% YoY increase. Paytm also has 12 lakh activated cards through partnerships with SBI Card, HDFC Bank, and Kotak Bank. Although its revenue reached <a href=\"https:\/\/paytm.com\/document\/ir\/agm\/fy\/-24\/Paytm_Annual_Report_2024.pdf\" target=\"_blank\" rel=\"noopener\">Rs.9,978 crore <\/a>in FY2024, the company faced a net loss margin of 14.3%. However, it reduced its debt, bringing the debt-to-equity ratio to 0.01.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Aether Industries Limited:<\/strong><\/h3>\n\n\n\n<p>Aether Industries Limited, founded in 2013 and based in Surat, Gujarat, specializes in manufacturing specialty chemicals. It focuses on advanced intermediates, serving industries like pharmaceuticals, agrochemicals, and oil and gas. From FY 2018 to FY 2024, Aether grew at a <a href=\"https:\/\/www.equentis.com\/blog\/what-is-cagr-compound-annual-growth-rate-meaning-formula\/\">CAGR<\/a> of 28.74%. The company is also a key player in CRAMS, using its advanced R&amp;D and Pilot Plant facilities. Aether is a member of the UN Global Compact Network India and has received the Silver EcoVadis Medal. It went public with an <a class=\"wpil_keyword_link\" href=\"https:\/\/www.equentis.com\/ipos\" title=\"IPO\" link=\"linked\" id=\"939\">IPO<\/a> in June 2022. In FY 2024, Aether reported a total income of Rs.637.38 crore and a net profit of <a href=\"https:\/\/aether.co.in\/wp-content\/uploads\/2024\/02\/Annual%20Report%20FY%202023-24.pdf\" target=\"_blank\" rel=\"noopener\">Rs.82.49 crore<\/a>, marking a 37% drop compared to FY 2023.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\"><strong>Top 10 volume gainers stocks from NIFTY 500 today <\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>Sno<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Symbol<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Volume<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>Volume Change %<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">1<\/td><td class=\"has-text-align-center\" data-align=\"center\">JUBLPHARMA<\/td><td class=\"has-text-align-center\" data-align=\"center\">6495204<\/td><td class=\"has-text-align-center\" data-align=\"center\">2013.86 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">2<\/td><td class=\"has-text-align-center\" data-align=\"center\">APLLTD<\/td><td class=\"has-text-align-center\" data-align=\"center\">2964489<\/td><td class=\"has-text-align-center\" data-align=\"center\">778.75 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">3<\/td><td class=\"has-text-align-center\" data-align=\"center\">DOMS<\/td><td class=\"has-text-align-center\" data-align=\"center\">633506<\/td><td class=\"has-text-align-center\" data-align=\"center\">452.50 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">4<\/td><td class=\"has-text-align-center\" data-align=\"center\">EPL<\/td><td class=\"has-text-align-center\" data-align=\"center\">7804504<\/td><td class=\"has-text-align-center\" data-align=\"center\">292.45 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">5<\/td><td class=\"has-text-align-center\" data-align=\"center\">ANANDRATHI<\/td><td class=\"has-text-align-center\" data-align=\"center\">152247<\/td><td class=\"has-text-align-center\" data-align=\"center\">284.05 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">6<\/td><td class=\"has-text-align-center\" data-align=\"center\">NIACL<\/td><td class=\"has-text-align-center\" data-align=\"center\">4477489<\/td><td class=\"has-text-align-center\" data-align=\"center\">265.59 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">7<\/td><td class=\"has-text-align-center\" data-align=\"center\">GRANULES<\/td><td class=\"has-text-align-center\" data-align=\"center\">7424632<\/td><td class=\"has-text-align-center\" data-align=\"center\">217.93 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">8<\/td><td class=\"has-text-align-center\" data-align=\"center\">DABUR<\/td><td class=\"has-text-align-center\" data-align=\"center\">6213076<\/td><td class=\"has-text-align-center\" data-align=\"center\">209.69 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">9<\/td><td class=\"has-text-align-center\" data-align=\"center\">NH<\/td><td class=\"has-text-align-center\" data-align=\"center\">1229140<\/td><td class=\"has-text-align-center\" data-align=\"center\">209.34 %<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">10<\/td><td class=\"has-text-align-center\" data-align=\"center\">GLS<\/td><td class=\"has-text-align-center\" data-align=\"center\">1294328<\/td><td class=\"has-text-align-center\" data-align=\"center\">183.49 %<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">(source: NSE on 9th September 2024)<\/figcaption><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-ast-global-color-5-color has-vivid-red-background-color has-text-color has-background has-link-color wp-elements-d8af6bf8611dc999cadca191853dd950\">Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. Past performance is not indicative of future results.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\"><strong>Understanding the stocks of the list:<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>DOMS Industries Ltd.:<\/strong><\/h3>\n\n\n\n<p>DOMS Industries Limited, established in 2006, specializes in stationery and art products. It\u2019s the second-largest player in India\u2019s branded stationery and art market, holding 29% and 30% market share for pencils and mathematical instrument boxes in FY23. The company operates in over 40 countries and, in FY24, acquired a <a href=\"https:\/\/domsindia.com\/pdf\/Investor_Relations\/Investor_Presentation_and_Transcripts\/DOMS_Investor_Presentation_Q1FY25.pdf\" target=\"_blank\" rel=\"noopener\">51%<\/a> stake in SKIDO Industries to enter the Back-to-School segment. As of June 2024, DOMS had 7 product categories and a network of 4,750+ distributors, exporting to over 50 countries. In the June 2024 quarter, operating revenue grew 17.3% year-on-year, reaching Rs.445 crore, with a PAT of Rs.54.3 crore, reflecting a 49.5% increase. PAT margin stood at 12.2%.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>EPL Limited:<\/strong><\/h3>\n\n\n\n<p>EPL Limited, previously known as Essel Propack, is the largest global specialty packaging company. It produces laminated plastic tubes for industries such as beauty and cosmetics, Pharmaceuticals, Food, Oral, and Home. Blackstone Group acquired the company from the Essel Group in August 2019. EPL operates with a production capacity of about 8 billion tubes annually, with manufacturing units in the USA, Mexico, Colombia, Brazil, Poland, Germany, Egypt, China, the Philippines, and India. For FY2024, EPL reported revenue of \u20b91,280.5 crore and a net profit of \u20b9176.3 crore, down from \u20b92,002 crore last year. Despite the profit decline, EPL\u2019s stock delivered a 22.44% one-year return and a 7.84% three-year return as of 9th September 2024.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Anand Rathi Wealth Ltd.:<\/strong><\/h3>\n\n\n\n<p>Anand Rathi Wealth Ltd, founded on March 22, 1995, is a leading firm in India&#8217;s wealth solutions sector. It is ranked among the top three non-bank mutual fund distributors and provides a broad range of wealth solutions, financial products, and technology services. As of March 2024, 155 clients with assets exceeding \u20b910 crores achieved a 14.6% annual return and 46% lower risk than the <a href=\"https:\/\/www.equentis.com\/blog\/demystifying-the-nifty-50-a-look-at-indias-top-stocks\/\">NIFTY 50<\/a> Index using its 10-year strategy. In FY2024, Anand Rathi Wealth Ltd generated \u20b9752 crores in revenue, a 35% year-on-year increase. Approximately 52.4% of its clients have investible assets between \u20b95 crores and \u20b950 crores, though many now exceed \u20b950 crores. 23.6% of the company&#8217;s AUM comes from clients with assets over \u20b950 crores. Nearly 24% of clients are still under \u20b95 crores, and some have not fully invested their portfolios. In FY2024, the AUM was <a href=\"https:\/\/www.anandrathiwealth.in\/wealthpdf\/24may24\/AnnualReport2023-24.pdf\" target=\"_blank\" rel=\"noopener\">\u20b959,351 crores<\/a>, up 52% from the previous year, and the PAT was \u20b9226 crores, a 34% increase.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>New India Assurance Company Ltd:<\/strong><\/h3>\n\n\n\n<p>New India Assurance Company Ltd. is India&#8217;s largest non-life insurer, with around 86% of its stake held by the Government of India. Founded by Sir Dorabji Tata in 1919 and nationalized in 1973, it was one of four subsidiaries of the General Insurance Company of India (GIC) until GIC became a re-insurance company in 1999, granting New India Assurance autonomy. It holds a <a href=\"https:\/\/www.newindia.co.in\/about-us\" target=\"_blank\" rel=\"noopener\">B++ S<\/a>table FSR Rating and BBB+ Stable ICR Outlook from AM BEST and has been rated AAA\/Stable by CRISIL since 2014. In FY 2022-23, it won the General Insurance Company of the Year award from BFSI and the ETascent Stars of the Industry award for Excellence &amp; Leadership in BFSI. Leading the Indian non-life insurance market for over 50 years, its business reached Rs.18,800 crores by September 2023, showing a 7.06% growth from the previous year. For FY2024, it is nearly <a href=\"https:\/\/www.equentis.com\/blog\/10-debt-free-penny-stocks-to-buy-in-india\/\">debt-free<\/a> and pays a 28.1% dividend. As of FY2024, it generated a revenue of <a href=\"https:\/\/www.screener.in\/company\/NIACL\/consolidated\/\" target=\"_blank\" rel=\"noopener\">Rs.43,518 crore<\/a>, with a net profit of Rs.1,120 crore and a 5-year profit growth of 40%. In the June 2024 quarter, the net profit was Rs. 313 crore.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Granules India Limited:<\/strong><\/h3>\n\n\n\n<p>Granules India Ltd. and its subsidiaries specialize in producing and selling Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages. With four facilities in Hyderabad and Vizag, it has a total capacity of 40,000 TPA. In FY2024, the company&#8217;s revenue was Rs.4506.4 crore. Breakdown of revenue: APIs at Rs.986.6 crore (22%), PFIs at Rs.610.7 crore (14%), and Finished Dosages at Rs.2909 crore (64%). The company also provided a dividend yield of 0.21% as of FY2024. Additionally, the company stock generated returns of 113.15% over one year and 103.28% over three years as of 9th September 2024.<\/p>\n\n\n\n<p>Today&#8217;s gains, led by banking and consumer stocks, showed the market\u2019s attempts to stabilize. However, there are still worries about the U.S. economy, especially after last week\u2019s jobs data showed a slowdown in the labor market. While the growth in stocks may or may not last, it&#8217;s always good to keep a close eye on your portfolio in these unpredictable times.&nbsp;<\/p>\n\n\n\n<p class=\"has-ast-global-color-5-color has-vivid-red-background-color has-text-color has-background has-link-color wp-elements-9ce0f53ce9b064a07752f45f1a6f5b01\">Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis &#8211; Research &amp; Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by <a href=\"https:\/\/www.equentis.com\/blog\/sebi-registered-investment-advisor-meaning-eligibility\/\">SEBI<\/a>, membership of BASL &amp; the certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It rained IPOs today, with the Share Samadhan, Kross, and My Mudra Fincorp IPOs. The market welcomed the IPOs with [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":45082,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[948],"tags":[],"class_list":["post-45081","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-market-news"],"_links":{"self":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/45081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/comments?post=45081"}],"version-history":[{"count":3,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/45081\/revisions"}],"predecessor-version":[{"id":63303,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/posts\/45081\/revisions\/63303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/media\/45082"}],"wp:attachment":[{"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/media?parent=45081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/categories?post=45081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.equentis.com\/blog\/wp-json\/wp\/v2\/tags?post=45081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}